栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/04/13 | 2,538 | 2,545 | 2,493 | 2,529 | -1 | ±0% | 80,400 |
2018/04/12 | 2,521 | 2,561 | 2,504 | 2,530 | +6 | +0.2% | 76,400 |
2018/04/11 | 2,607 | 2,607 | 2,494 | 2,524 | -83 | -3.2% | 115,600 |
2018/04/10 | 2,625 | 2,647 | 2,585 | 2,607 | -28 | -1.1% | 73,000 |
2018/04/09 | 2,568 | 2,653 | 2,556 | 2,635 | +67 | +2.6% | 127,700 |
2018/04/06 | 2,593 | 2,611 | 2,532 | 2,568 | -79 | -3% | 215,100 |
2018/04/05 | 2,679 | 2,679 | 2,637 | 2,647 | -12 | -0.5% | 83,500 |
2018/04/04 | 2,667 | 2,668 | 2,634 | 2,659 | +12 | +0.5% | 77,800 |
2018/04/03 | 2,600 | 2,662 | 2,588 | 2,647 | +23 | +0.9% | 107,300 |
2018/04/02 | 2,681 | 2,681 | 2,624 | 2,624 | -56 | -2.1% | 88,700 |
2018/03/30 | 2,673 | 2,690 | 2,637 | 2,680 | +21 | +0.8% | 122,800 |
2018/03/29 | 2,642 | 2,665 | 2,620 | 2,659 | +24 | +0.9% | 208,100 |
2018/03/28 | 2,575 | 2,648 | 2,563 | 2,635 | +15 | +0.6% | 179,900 |
2018/03/27 | 2,575 | 2,625 | 2,560 | 2,620 | +60 | +2.3% | 153,000 |
2018/03/26 | 2,450 | 2,565 | 2,450 | 2,560 | +82.5 | +3.3% | 171,000 |
2018/03/23 | 2,510 | 2,540 | 2,467.5 | 2,477.5 | -82.5 | -3.2% | 190,200 |
2018/03/22 | 2,400 | 2,570 | 2,400 | 2,560 | +150 | +6.2% | 274,600 |
2018/03/20 | 2,405 | 2,422.5 | 2,387.5 | 2,410 | -30 | -1.2% | 106,600 |
2018/03/19 | 2,425 | 2,450 | 2,380 | 2,440 | -2.5 | -0.1% | 150,600 |
2018/03/16 | 2,482.5 | 2,490 | 2,435 | 2,442.5 | -40 | -1.6% | 112,600 |
2018/03/15 | 2,467.5 | 2,497.5 | 2,450 | 2,482.5 | +7.5 | +0.3% | 105,800 |
2018/03/14 | 2,462.5 | 2,485 | 2,447.5 | 2,475 | -25 | -1% | 112,600 |
2018/03/13 | 2,460 | 2,505 | 2,447.5 | 2,500 | +40 | +1.6% | 138,000 |
2018/03/12 | 2,460 | 2,480 | 2,445 | 2,460 | +35 | +1.4% | 84,200 |
2018/03/09 | 2,515 | 2,530 | 2,417.5 | 2,425 | -70 | -2.8% | 218,200 |
2018/03/08 | 2,550 | 2,555 | 2,470 | 2,495 | -35 | -1.4% | 120,600 |
2018/03/07 | 2,525 | 2,540 | 2,477.5 | 2,530 | ±0 | ±0% | 75,400 |
2018/03/06 | 2,485 | 2,535 | 2,485 | 2,530 | +60 | +2.4% | 85,600 |
2018/03/05 | 2,480 | 2,500 | 2,455 | 2,470 | -5 | -0.2% | 86,800 |
2018/03/02 | 2,430 | 2,525 | 2,430 | 2,475 | -2.5 | -0.1% | 146,600 |
2018/03/01 | 2,555 | 2,560 | 2,457.5 | 2,477.5 | -112.5 | -4.3% | 218,000 |
2018/02/28 | 2,620 | 2,650 | 2,590 | 2,590 | -50 | -1.9% | 159,200 |
2018/02/27 | 2,575 | 2,650 | 2,565 | 2,640 | +75 | +2.9% | 166,800 |
2018/02/26 | 2,610 | 2,610 | 2,555 | 2,565 | +5 | +0.2% | 96,800 |
2018/02/23 | 2,550 | 2,570 | 2,540 | 2,560 | -5 | -0.2% | 58,000 |
2018/02/22 | 2,500 | 2,565 | 2,500 | 2,565 | +35 | +1.4% | 113,000 |
2018/02/21 | 2,460 | 2,550 | 2,430 | 2,530 | +52.5 | +2.1% | 140,000 |
2018/02/20 | 2,475 | 2,500 | 2,442.5 | 2,477.5 | -10 | -0.4% | 114,600 |
2018/02/19 | 2,450 | 2,490 | 2,437.5 | 2,487.5 | +70 | +2.9% | 118,600 |
2018/02/16 | 2,402.5 | 2,437.5 | 2,375 | 2,417.5 | +97.5 | +4.2% | 263,200 |
2018/02/15 | 2,285 | 2,330 | 2,267.5 | 2,320 | +37.5 | +1.6% | 126,200 |
2018/02/14 | 2,307.5 | 2,322.5 | 2,257.5 | 2,282.5 | -30 | -1.3% | 167,200 |
2018/02/13 | 2,360 | 2,367.5 | 2,297.5 | 2,312.5 | -60 | -2.5% | 253,800 |
2018/02/09 | 2,420 | 2,437.5 | 2,352.5 | 2,372.5 | -132.5 | -5.3% | 199,000 |
2018/02/08 | 2,450 | 2,540 | 2,450 | 2,505 | +85 | +3.5% | 194,400 |
2018/02/07 | 2,515 | 2,525 | 2,420 | 2,420 | +37.5 | +1.6% | 234,000 |
2018/02/06 | 2,530 | 2,530 | 2,345 | 2,382.5 | -197.5 | -7.7% | 290,400 |
2018/02/05 | 2,575 | 2,605 | 2,555 | 2,580 | -15 | -0.6% | 238,600 |
2018/02/02 | 2,540 | 2,610 | 2,540 | 2,595 | +85 | +3.4% | 275,800 |
2018/02/01 | 2,440 | 2,520 | 2,440 | 2,510 | +85 | +3.5% | 228,800 |
1601~
1650
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 30.69倍 | 1.75倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム